Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dougan

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Clinical Investigation|May 4, 2011
A dual role for the immune response in a mouse model of inflammation-associated lung cancerMichael Dougan, Danan Li, Donna Neuberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
Liver biopsy findings in patients on immune checkpoint inhibitorsJustine V Cohen, Michael Dougan, Leyre Zubiri, et al.
Gastro Hep Advances|September 19, 2024
Histopathologic Features of Unmasked Inflammatory Bowel Disease Following Immune Checkpoint Inhibitor Therapy in Colon BiopsiesM Lisa Zhang, Khalid Algarrahi, Jamie DiCarlo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2023
Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor HepatitisMike Wang, Kerry L Reynolds, Kamaneh Montazeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
Accelerating the Evolution of Immune-Related Enterocolitis ManagementDavid M Faleck, Michael Dougan, Monique Tello, et al.
Cancer Immunology Research|February 6, 2020
Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody FragmentsYushu Joy Xie, Michael Dougan, Jessica R Ingram, et al.
Journal for Immunotherapy of Cancer|August 24, 2019
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse eventsYousef R Badran, Justine V Cohen, Priscilla K Brastianos, et al.
Journal of General Internal Medicine|November 10, 2021
The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.GovChana A Sacks, Crystal M North, Molly Wolf, et al.
Frontiers in Immunology|September 30, 2022
Human differentiated eosinophils release IL-13 in response to IL-33 stimulationAmiko M Uchida, Gabrielle Ro, Li Qiang, et al.
Frontiers in Immunology|May 2, 2022
Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint TherapyAyo S Falade, Kerry L Reynolds, Leyre Zubiri, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Clinical Investigation|May 4, 2011
A dual role for the immune response in a mouse model of inflammation-associated lung cancerMichael Dougan, Danan Li, Donna Neuberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 5, 2020
Liver biopsy findings in patients on immune checkpoint inhibitorsJustine V Cohen, Michael Dougan, Leyre Zubiri, et al.
Gastro Hep Advances|September 19, 2024
Histopathologic Features of Unmasked Inflammatory Bowel Disease Following Immune Checkpoint Inhibitor Therapy in Colon BiopsiesM Lisa Zhang, Khalid Algarrahi, Jamie DiCarlo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 24, 2023
Tofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor HepatitisMike Wang, Kerry L Reynolds, Kamaneh Montazeri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2023
Accelerating the Evolution of Immune-Related Enterocolitis ManagementDavid M Faleck, Michael Dougan, Monique Tello, et al.
Cancer Immunology Research|February 6, 2020
Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody FragmentsYushu Joy Xie, Michael Dougan, Jessica R Ingram, et al.
Journal for Immunotherapy of Cancer|August 24, 2019
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse eventsYousef R Badran, Justine V Cohen, Priscilla K Brastianos, et al.
Journal of General Internal Medicine|November 10, 2021
The Landscape of COVID-19 Research in the United States: a Cross-sectional Study of Randomized Trials Registered on ClinicalTrials.GovChana A Sacks, Crystal M North, Molly Wolf, et al.
Frontiers in Immunology|September 30, 2022
Human differentiated eosinophils release IL-13 in response to IL-33 stimulationAmiko M Uchida, Gabrielle Ro, Li Qiang, et al.
Frontiers in Immunology|May 2, 2022
Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint TherapyAyo S Falade, Kerry L Reynolds, Leyre Zubiri, et al.
Pageof 15